Navigation Links
TomoTherapy raises $223 million in IPO

Madison, Wis.- TomoTherapy has raised $223 million, the amount it had hoped to raise, in an initial public offering that was completed earlier today.

TomoTherapy, a portfolio company of Baird Venture Partners I, offered common stock at $19 per share, and expects to receive $185 million in net......

Full article >>> estors of Madison, first invested in TomoTherapy in March of 1999 and held the largest number of TomoTherapy shares prior to the IPO.

Related articles

TomoTherapy revises IPO money target

Hospital named for Madame Curie installs TomoTherapy syste......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/09/07


Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. TomoTherapy opens technical training center
3. TomoTherapy revises IPO money target
4. Hospital named for Madame Curie installs TomoTherapy system
5. TomoTherapy files registration statement for IPO
6. TomoTherapy to sell medical devices in India
7. TomoTherapy sees sustained market advantage
8. TomoTherapys 100th radiology system reaches public sector
9. TomoTherapy extends reach to Germany
10. Cash-rich TomoTherapy has no plans for IPO
11. City of Hope adds second TomoTherapy system
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... 30, 2016 The global Pyrogen ... hold a dominant share in the overall market. The ... Inc., and Merck KGaA, held a lion,s share of ... Research observes that these companies are expected to retain ... that are do not require rabbit pyrogen testing along ...
(Date:11/30/2016)... 2016  Tempus, a technology company focused on ... Abramson Cancer Center have partnered to better determine ... immunotherapy treatment based on next generation genomic and ... a research collaboration, Tempus will provide sequencing and ... data to Penn. Utilizing next-generation sequencing, machine learning ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader in small-molecule ... of the latest FDA guidance on pharmaceutical cocrystals as drug substance . ... , The event follows the successful November 15th event that took place ...
(Date:11/30/2016)... Toronto, ON (PRWEB) , ... November 30, 2016 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) (announced on November 3, 2016) blocked propagation of toxic, prion-like forms ...
Breaking Biology Technology:
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
Breaking Biology News(10 mins):